Invited PerspectiveSULFURETIN (cas 120-05-8) has therapeutic activity against acquired lymphedema by reducing adipogenesis
-
Add time:08/29/2019 Source:sciencedirect.com
Acquired lymphedema is a pathological condition associated with lymphatic dysfunction caused by surgical treatments for cancer. Although global estimates of the prevalence of acquired lymphedema have been rising, there are currently no effective therapeutics available. Since adipose tissue accumulation is a clinical hallmark of lymphedema, we hypothesized that regulation of adipogenesis in lymphedematous tissue could be used as a therapeutic intervention against lymphedema. Toward this, we investigated the possibility of anti-adipogenic 30% ethanol Rhus verniciflua Stokes (RVS) extract as a potential lymphedema treatment. Oral administration of RVS extract ameliorated volumetric symptoms of lymphedema in a mouse model. RVS administration also reduced adipose tissue accumulation in lymphedematous tissue and downregulated expression of adipocyte markers, including Pparγ and Fabp4. Sulfuretin was identified as a major bioactive compound in the 30% ethanol RVS extract in liquid chromatography-mass spectrometry analysis. Similar to the activities of RVS, sulfuretin inhibited adipocyte differentiation in 3T3-L1 preadipocytes. Moreover, treatment with sulfuretin on lymphedema-induced mice reduced lymphedema volume, decreased the expression of adipogenic markers, but induced the expression of markers associated with lymphangiogenesis. Taken together, our data raise the possibility that sulfuretin might be used in therapeutic interventions against acquired lymphedema.
We also recommend Trading Suppliers and Manufacturers of SULFURETIN (cas 120-05-8). Pls Click Website Link as below: cas 120-05-8 suppliers
Prev:SULFURETIN (cas 120-05-8), a natural Src family kinases inhibitor for suppressing solar UV-induced skin aging
Next:Involvement of the Nrf2/HO-1 signaling pathway in SULFURETIN (cas 120-05-8)-induced protection against amyloid beta25–35 neurotoxicity) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- SULFURETIN (cas 120-05-8) isolated from heartwood of Rhus verniciflua inhibits LPS-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines expression via the down-regulation of NF-κB in RAW 264.7 murine macrophage cells09/05/2019
- Anti-inflammatory effects of SULFURETIN (cas 120-05-8) from Rhus verniciflua Stokes via the induction of heme oxygenase-1 expression in murine macrophages09/04/2019
- SULFURETIN (cas 120-05-8), a major flavonoid isolated from Rhus verniciflua, ameliorates experimental arthritis in mice09/03/2019
- SULFURETIN (cas 120-05-8) inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells09/02/2019
- SULFURETIN (cas 120-05-8)-induced miR-30C selectively downregulates cyclin D1 and D2 and triggers cell death in human cancer cell lines09/01/2019
- SULFURETIN (cas 120-05-8) attenuates allergic airway inflammation in mice08/31/2019
- Involvement of the Nrf2/HO-1 signaling pathway in SULFURETIN (cas 120-05-8)-induced protection against amyloid beta25–35 neurotoxicity08/30/2019
- SULFURETIN (cas 120-05-8), a natural Src family kinases inhibitor for suppressing solar UV-induced skin aging08/28/2019
